Jeffrey Frelick
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey Frelick
Jeffrey Frelick is recorded as CEO at Bone Biologics Corp (BBLG). The proxy statement of Bone Biologics Corp reports total compensation of $426,269 for Jeffrey Frelick in fiscal 2025, including a base salary of $300,000. Disclosed compensation is on record for 5 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Bone Biologics Corp
Other people whose current roles at this company are on record from its filings.
- Bruce Stroever Chairman
- Deina H. Walsh CFO
- Phil Meikle Board Member
- Philip Meikle Board Member
- Robert E. Gagnon Board Member
- Robert Gagnon Board Member
- Siddhesh Angle Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Bone Biologics Corp (BBLG) | Chief Executive Officer and President | $300,000 | $426,269 |
| 2024 | Bone Biologics Corp (BBLG) | Chief Executive Officer and President | $300,000 | $384,897 |
| 2023 | Bone Biologics Corp (BBLG) | Chief Executive Officer and President | $300,000 | $376,600 |
| 2022 | Bone Biologics Corp (BBLG) | Chief Executive Officer and President | $300,000 | $414,715 |
| 2021 | Bone Biologics Corp (BBLG) | Chief Executive Officer and President | $240,000 | $290,000 |
Recent activity
No call appearances or filed executive changes recorded yet.